Our mental health might benefit from the use of virtual psychedelics?

The Virtual Reality Experience Captures What It’s Like to Be High on LSD and Mushrooms in the metaverse

Isness-D is a virtual reality (VR) experience designed for therapeutic purposes that is capable of creating a sensation of self-transcendence comparable to that produced by a moderate dosage of LSD or magic mushrooms. David Glowacki, a physicist and digital artist, had a near-death experience around 15 years ago, and he used that event as inspiration for developing the app.

Glowacki asserts that his body morphed into a brilliant ball of light over the course of the accident, and that this light ball started to blend with the environment around him. He claims to have experienced a sense of true tranquility, which is a sensation he wishes to convey to others via his mind-altering virtual reality experience.

Same impact as a medium dosage of psilocybin

Isness-D was demonstrated to have the same impact as a medium dosage of psilocybin, which is the major component of psychedelic mushrooms, or LSD, in accordance with a research that was published in Nature Scientific Reports. The experience, on its own, sounds exactly as mind-bending as you would expect it to be.

Isness-D is a multiperson experience that provides assistance for as many as four to five individuals at once, irrespective of where in the world they may be located.

Each individual user is shown as a sphere of light that is encircled by a cloud of smoke. At the very least, this is how everything gets started.

Users’ bodies merge with one another as

they take part in a process referred to as “energetic coalescence,” which results in a sense of “oneness” quite similar to the sensation that Glowacki had. Isness-D produces an experience that is quite similar to that produced by taking 20 milligrams of psilocybin or 200 micrograms of LSD, according to the findings of a research in which 75 people participated.

In a conversation with MIT Technology Review, Agnieszka Sekula, a PhD candidate at the Centre for Human Psychopharmacology, described the experience of virtual reality (VR) as “the impression of entirely forgetting about the presence of the exterior world.” “There is thus obviously a connection there to the feeling of witnessing an other world when under the influence of psychedelics, one that seems more genuine than what is really out there,”

As part of a collaboration with the virtual reality (VR) firm aNUma, the Isness-D platform is presently being put to use as a therapeutic tool for cancer patients.

Interested in learning more about VR?